Clinical trial
Treatment of Cholestatic Pruritus With Sertraline
NCT00058903 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00058903 |
|---|---|
| Title | Treatment of Cholestatic Pruritus With Sertraline |
| Official title | Treatment of Cholestatic Pruritus With Sertraline |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pruritus, Liver Cirrhosis, Biliary, Hepatitis C |
| Intervention type | Drug |
| Interventions | sertraline |
| Enrollment | 40 |
| Start date | Apr 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Apr 16, 2003 |
| Last update posted | Jan 13, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: